Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Chronic Obstructive Pulmonary Disease (COPD) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugsmarket, defines the market attractiveness level of Chronic Obstructive Pulmonary Disease (COPD) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chronic Obstructive Pulmonary Disease (COPD) Drugs industry, describes the types of Chronic Obstructive Pulmonary Disease (COPD) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Obstructive Pulmonary Disease (COPD) Drugs market and the development prospects and opportunities of Chronic Obstructive Pulmonary Disease (COPD) Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Obstructive Pulmonary Disease (COPD) Drugs market in Chapter 13.
By Player:
Sunovion Pharmaceuticals
Boehringer Ingelheim
SPIRIVA
Perforomist
Novartis
Striverdi
Almirall
GSK
By Type:
Type 1
Type 2
Type 3
By End-User:
Application 1
Application 2
Application 3
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chronic Obstructive Pulmonary Disease (COPD) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Analysis and Outlook to 2022
-
7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
-
7.7 South Korea Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (2017-2022)
8 Region and Country-wise Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Analysis and Outlook to 2028
-
8.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast (2022-2028)
9 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)
10 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
11 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Competitive Analysis
-
14.1 Sunovion Pharmaceuticals
-
14.1.1 Sunovion Pharmaceuticals Company Details
-
14.1.2 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Details
-
14.2.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.3 SPIRIVA
-
14.3.1 SPIRIVA Company Details
-
14.3.2 SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.4 Perforomist
-
14.4.1 Perforomist Company Details
-
14.4.2 Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.6 Striverdi
-
14.6.1 Striverdi Company Details
-
14.6.2 Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.7 Almirall
-
14.7.1 Almirall Company Details
-
14.7.2 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
14.8 GSK
-
14.8.1 GSK Company Details
-
14.8.2 GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chronic Obstructive Pulmonary Disease (COPD) Drugs
-
Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Picture
-
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Country (2017-2022)
-
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table SPIRIVA (Foundation Year, Company Profile and etc.)
-
Table SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table Perforomist (Foundation Year, Company Profile and etc.)
-
Table Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table Striverdi (Foundation Year, Company Profile and etc.)
-
Table Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table Almirall (Foundation Year, Company Profile and etc.)
-
Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Product and Service
-
